Elutia (ELUT) Enterprise Value Growth (3y) (2022 - 2026)
Elutia (ELUT) Enterprise Value Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn |
| 3 | Medtronic | 108.81 Bn | 99.59 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.39 Bn | 66.94 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.28 Bn | 44.60 Bn | 1.29 Bn |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.30 Bn | 26.01 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn |
| 10 | Elutia | 40.03 Mn | 11.54 Mn | 1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.19% |
| Dec 31, 2025 | -28.86% |
| Sep 30, 2025 | 16.47% |
| Jun 30, 2025 | 19.85% |
| Mar 31, 2025 | 7.84% |
| Dec 31, 2024 | 24.22% |
| Sep 30, 2024 | -4.39% |
| Jun 30, 2024 | 13.77% |
| Mar 31, 2024 | 25.62% |
| Dec 31, 2023 | 21.29% |
| Sep 30, 2023 | -106.69% |
| Jun 30, 2023 | -107.53% |
| Mar 31, 2023 | -166.05% |
| Dec 31, 2022 | -87.19% |
| Sep 30, 2022 | -140.96% |